Radiation recall myositis resistant to conventional therapies Clinical improvement with botulinum toxin A intervention
Radiation Recall Myositis (RRM) is a rare phenomenon that occurs after radiotherapy and chemotherapy. Gemcitabine is the most commonly implicated agent in its development.
Authors
- Ahmet Basari
Publication Details
- Journal
- International Journal of Clinical & Medical Case Studies
- Published
- 2025-07-15
- DOI
- https://doi.org/10.52768/3067-3852/1024
- Primary Topic
- Chemotherapy-related skin toxicity
- Type
- article
- Field-Weighted Citation Impact
- 0.00